Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 31)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A MNTA: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
7-Feb-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: MOMENTA PHARMACEUTICALS INC 5 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: BPAX , CYTX , MNTA , NVAX , TTNP , TRMS , XNPT -- DRUGS 3 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: MOMENTA PHARMACE -- MNTA 1 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of MOMENTA PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
31-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Momenta Pharmaceuticals, Inc. 40 $65 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: MOMENTA PHARMACEUTICALS INC 5 $25 View Abstract
26-Jan-10 EconomicInvestor N/A "The Economy Matters" Report for MNTA: the economy's impact on MNTA's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: MOMENTA PHARMACEUTICALS INC 5 $25 View Abstract
22-Jan-10 Zacks Investment Research Inc. N/A MOMENTA PHARMA (MNTA) Zacks Company Snapshot 1 $10 View Abstract
Next 20

Independent Reports (Showing 1 to 10 of 31)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A MNTA: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
7-Feb-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: MOMENTA PHARMACEUTICALS INC 5 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: BPAX , CYTX , MNTA , NVAX , TTNP , TRMS , XNPT -- DRUGS 3 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: MOMENTA PHARMACE -- MNTA 1 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of MOMENTA PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
31-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Momenta Pharmaceuticals, Inc. 40 $65 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: MOMENTA PHARMACEUTICALS INC 5 $25 View Abstract
26-Jan-10 EconomicInvestor N/A "The Economy Matters" Report for MNTA: the economy's impact on MNTA's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: MOMENTA PHARMACEUTICALS INC 5 $25 View Abstract
22-Jan-10 Zacks Investment Research Inc. N/A MOMENTA PHARMA (MNTA) Zacks Company Snapshot 1 $10 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.